Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

PURPOSE: Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall survival. Insulin resistance is defined as a pathological condit...

全面介紹

Na minha lista:
書目詳細資料
發表在:World J Surg Oncol
Main Authors: Alan, Ozkan, Akin Telli, Tugba, Aktas, Bilge, Koca, Sinan, Ökten, Ilker Nihat, Hasanov, Rahib, Basoglu, Tugba, Arikan, Rukiye, Demircan, Nazim Can, Ercelep, Ozlem, Kaya, Serap, Ugurlu, Mustafa Umit, Kaya, Handan, Akgul Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488234/
https://ncbi.nlm.nih.gov/pubmed/32907593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02019-y
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍